Research library

Selected reports, profiles and newsletters, in one place.

WallStreet Research has published hundreds of reports over five decades, distributed to over 200,000 investor subscribers worldwide. These are the reports and profiles featured online, covering emerging growth companies on NASDAQ, NYSE, AMEX, OTC Markets, TSX, CSE and global exchanges.

47Featured online
8Market groups
1998 to 2026Years of coverage
Skinvisible, Inc. logo

Skinvisible, Inc.

OTCQB: SKVIPharmaceuticals and drug delivery

Research Report, 12 pages

Develops topical and transdermal products made with its patented skin delivery system, Invisicare®, and filed a provisional patent for a transdermal obesity medication delivery method.

Borqs Technologies, Inc. logo

Borqs Technologies, Inc.

OTCQB: BRQSFInternet of Things

Updated Research Report, 11 pages

A global leader in embedded software and products for the Internet of Things, offering Android based smart connected devices, 5G and end to end cloud services.

Cytta Corp. logo

Cytta Corp.

OTCQB: CYCAVideo streaming technology

Initial Research Report, 7 pages

Develops proprietary technology that changes how video is streamed, consumed, transferred and stored, including advanced video compression and portable hardware systems.

Halo Labs, Inc. logo

Halo Labs, Inc.

OTCQX: AGEEF, NEO: HALOCannabis

Updated Research Report, 12 pages

A global cannabis cultivation, extraction, distribution and branded product company with expertise across all major cannabis manufacturing processes.

Brainstorm Cell Therapeutics, Inc. logo

Brainstorm Cell Therapeutics, Inc.

OTC BB: BCLICell therapy

Initial Research Report

A development-stage biotechnology company developing adult stem cell therapies for neurodegenerative diseases such as Parkinson's, ALS and multiple sclerosis. Its NurOwn technology, licensed from Tel Aviv University, turns a patient's own bone marrow stem cells into neural-like cells.

Uplisted to NASDAQ: BCLI

WallStreet Research provides research services to publicly traded companies on a fee basis, the nature and amount of which is fully disclosed in each report. Read the Disclaimer